Cargando…

Local anaesthesia vs. general anaesthesia for percutaneous microwave ablation in hepatocellular carcinoma: efficacy, safety, and cost analysis

PURPOSE: To compare the efficacy, safety, and cost of local anaesthesia and general anaesthesia modalities for percutaneous microwave ablation as a curative treatment for hepatocellular carcinoma patients. METHODS: This comparative, retrospective study analysed 175 patients who were treated for hepa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhan, Jing-Ying, Zhao, Dan, Tang, Zhen-Lei, Leng, Hao-Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523566/
https://www.ncbi.nlm.nih.gov/pubmed/37771440
http://dx.doi.org/10.3389/fonc.2023.1186133
_version_ 1785110588719890432
author Zhan, Jing-Ying
Zhao, Dan
Tang, Zhen-Lei
Leng, Hao-Qun
author_facet Zhan, Jing-Ying
Zhao, Dan
Tang, Zhen-Lei
Leng, Hao-Qun
author_sort Zhan, Jing-Ying
collection PubMed
description PURPOSE: To compare the efficacy, safety, and cost of local anaesthesia and general anaesthesia modalities for percutaneous microwave ablation as a curative treatment for hepatocellular carcinoma patients. METHODS: This comparative, retrospective study analysed 175 patients who were treated for hepatocellular carcinoma (HCC) from July 2015 to September 2020. Conventional transcatheter arterial chemoembolization (cTACE) combined with sequential percutaneous microwave ablation (MWA) was performed on every lesion in every patient. Patients were divided into two cohorts according to the anaesthesia modality applied during MWA. To investigate the differences in efficacy between the two groups, overall survival (OS) and local recurrence-free survival (LRFS) were estimated by the Kaplan−Meier method and compared by the log-rank test. Cost and safety between the two groups were also compared accordingly. RESULTS: There were 105 patients with 128 HCC lesions in the local anaesthesia (LA) group and 70 patients with 107 lesions in the general anaesthesia (GA) group. There were no significant differences in OS (P = 0.798) or LRFS (P = 0.406) between the two groups. Fifty-two pairs of patients were matched with 77 lesions in the GA group and 67 lesions in the LA group after PSM. There was no significant difference in OS (P = 0.522) or LRFS (P = 0.410) between the two groups. Compared to the LA group, the GA group had longer operations, consumed more medical resources, had a heavier financial burden, and experienced more anaesthesia adverse events. There was no significant difference in the incidence of post-ablation pain (p=0.487), fever (P=0.678), nausea or vomiting (P=0.808), mild liver dysfunction (P=0.753), haemolytic uraemic syndrome (P=0.595), pleural effusion (P=0.622), liver abscess (0.544), asymptomatic perihepatic fluid (0.703) or subcapsular liver hemorrhage (P=0.666) between the two groups. CONCLUSION: Due to the higher cost and adverse events of general anaesthesia, local anaesthesia may be more suitable for ablation procedures for HCC patients within the Milan criteria.
format Online
Article
Text
id pubmed-10523566
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105235662023-09-28 Local anaesthesia vs. general anaesthesia for percutaneous microwave ablation in hepatocellular carcinoma: efficacy, safety, and cost analysis Zhan, Jing-Ying Zhao, Dan Tang, Zhen-Lei Leng, Hao-Qun Front Oncol Oncology PURPOSE: To compare the efficacy, safety, and cost of local anaesthesia and general anaesthesia modalities for percutaneous microwave ablation as a curative treatment for hepatocellular carcinoma patients. METHODS: This comparative, retrospective study analysed 175 patients who were treated for hepatocellular carcinoma (HCC) from July 2015 to September 2020. Conventional transcatheter arterial chemoembolization (cTACE) combined with sequential percutaneous microwave ablation (MWA) was performed on every lesion in every patient. Patients were divided into two cohorts according to the anaesthesia modality applied during MWA. To investigate the differences in efficacy between the two groups, overall survival (OS) and local recurrence-free survival (LRFS) were estimated by the Kaplan−Meier method and compared by the log-rank test. Cost and safety between the two groups were also compared accordingly. RESULTS: There were 105 patients with 128 HCC lesions in the local anaesthesia (LA) group and 70 patients with 107 lesions in the general anaesthesia (GA) group. There were no significant differences in OS (P = 0.798) or LRFS (P = 0.406) between the two groups. Fifty-two pairs of patients were matched with 77 lesions in the GA group and 67 lesions in the LA group after PSM. There was no significant difference in OS (P = 0.522) or LRFS (P = 0.410) between the two groups. Compared to the LA group, the GA group had longer operations, consumed more medical resources, had a heavier financial burden, and experienced more anaesthesia adverse events. There was no significant difference in the incidence of post-ablation pain (p=0.487), fever (P=0.678), nausea or vomiting (P=0.808), mild liver dysfunction (P=0.753), haemolytic uraemic syndrome (P=0.595), pleural effusion (P=0.622), liver abscess (0.544), asymptomatic perihepatic fluid (0.703) or subcapsular liver hemorrhage (P=0.666) between the two groups. CONCLUSION: Due to the higher cost and adverse events of general anaesthesia, local anaesthesia may be more suitable for ablation procedures for HCC patients within the Milan criteria. Frontiers Media S.A. 2023-09-12 /pmc/articles/PMC10523566/ /pubmed/37771440 http://dx.doi.org/10.3389/fonc.2023.1186133 Text en Copyright © 2023 Zhan, Zhao, Tang and Leng https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhan, Jing-Ying
Zhao, Dan
Tang, Zhen-Lei
Leng, Hao-Qun
Local anaesthesia vs. general anaesthesia for percutaneous microwave ablation in hepatocellular carcinoma: efficacy, safety, and cost analysis
title Local anaesthesia vs. general anaesthesia for percutaneous microwave ablation in hepatocellular carcinoma: efficacy, safety, and cost analysis
title_full Local anaesthesia vs. general anaesthesia for percutaneous microwave ablation in hepatocellular carcinoma: efficacy, safety, and cost analysis
title_fullStr Local anaesthesia vs. general anaesthesia for percutaneous microwave ablation in hepatocellular carcinoma: efficacy, safety, and cost analysis
title_full_unstemmed Local anaesthesia vs. general anaesthesia for percutaneous microwave ablation in hepatocellular carcinoma: efficacy, safety, and cost analysis
title_short Local anaesthesia vs. general anaesthesia for percutaneous microwave ablation in hepatocellular carcinoma: efficacy, safety, and cost analysis
title_sort local anaesthesia vs. general anaesthesia for percutaneous microwave ablation in hepatocellular carcinoma: efficacy, safety, and cost analysis
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523566/
https://www.ncbi.nlm.nih.gov/pubmed/37771440
http://dx.doi.org/10.3389/fonc.2023.1186133
work_keys_str_mv AT zhanjingying localanaesthesiavsgeneralanaesthesiaforpercutaneousmicrowaveablationinhepatocellularcarcinomaefficacysafetyandcostanalysis
AT zhaodan localanaesthesiavsgeneralanaesthesiaforpercutaneousmicrowaveablationinhepatocellularcarcinomaefficacysafetyandcostanalysis
AT tangzhenlei localanaesthesiavsgeneralanaesthesiaforpercutaneousmicrowaveablationinhepatocellularcarcinomaefficacysafetyandcostanalysis
AT lenghaoqun localanaesthesiavsgeneralanaesthesiaforpercutaneousmicrowaveablationinhepatocellularcarcinomaefficacysafetyandcostanalysis